-
19 votes
-
Psilocybin therapy alters prefrontal and limbic brain circuitry in alcohol use disorder
17 votes -
How Chinese organized crime dominates America’s illicit marijuana market
12 votes -
The war on recovery: how the US is sabotaging its best tools to prevent deaths in the opioid epidemic
17 votes -
Oregon decriminalized drugs. Voters now regret it.
32 votes -
Cystic fibrosis breakthrough has given patients a chance to live longer
18 votes -
Single dose of clinical-grade LSD provides immediate and lasting relief from anxiety, wins approval for phase III trials
69 votes -
US prescription market hamstrung for nine days (so far) by ransomware attack
39 votes -
The cheapest cocaine on Earth?
9 votes -
A US drugmaker’s feud with the DEA is exacerbating the ADHD meds crisis
36 votes -
Germany's new cannabis law to pass this week and take effect in April
17 votes -
AstraZeneca unveils successes in treatment of lung cancer – best-selling Tagrisso drug slows progression of most common form of the disease at an early stage
22 votes -
Niacin has long been a public health darling. But an excess could be bad for the heart, study suggests.
15 votes -
Senators ask CEOs why their drugs cost so much more in the US
60 votes -
Researchers find response to ketamine depends on opioid pathways, but varies by sex
10 votes -
Research at the heart of a US lawsuit against the abortion pill has been retracted
28 votes -
Secretive US right wing advocacy group promotes model legislation to limit public nuisance claims like those responsible for tobacco and opioid verdicts
18 votes -
US Senator Bernie Sanders set to interrogate pharma executives about prices
33 votes -
EBay will pay $59 million settlement over pill presses sold online as US undergoes overdose epidemic
10 votes -
The man in room 117 – Andrey Shevelyov would rather live on the street than take antipsychotic medication. Should it be his decision to make?
21 votes -
US FDA recommends easing restrictions on marijuana
62 votes -
Why are antidepressants so popular in Iceland? | Mindset
6 votes -
Inside the world's highest tech prison - HMP Fosse Way
12 votes -
Psychoactive drug ibogaine effectively treats traumatic brain injury in special ops military vets
31 votes -
Can Denmark's world-beating drugs maker Novo Nordisk stay ahead after Wegovy propelled them into the big league?
8 votes -
Scientists hail new antibiotic that can kill drug-resistant bacteria
13 votes -
Aripiprazole (Abilify and generic brands): risk of pathological gambling
14 votes -
US President Joe Biden pardons thousands on federal marijuana charges, commutes others
79 votes -
How two US pharmacists figured out that oral phenylephrine decongestants don’t work
32 votes -
Moderna, Merck vaccine with Keytruda cuts risk of deadly skin cancer returning in half, data says
9 votes -
New lifesaving malaria vaccines need to be available now
7 votes -
The US Supreme Court will rule on limits to the use of Mifeprestone, a commonly used abortion medication
16 votes -
The business of bad medicine
4 votes -
Whats a drug that you would never try?
For me its meth. I had an online friend who developed schizophrenia and addiction from it. As well as it just seeming unappealing to me I think the risk from using it are too much.
52 votes -
Semaglutide for weight loss
Has anyone tried it out? There's currently a preventative healthcare initiative going on in my country where they start screening people over 40 for chronic or potentially chronic conditions. I...
Has anyone tried it out? There's currently a preventative healthcare initiative going on in my country where they start screening people over 40 for chronic or potentially chronic conditions.
I went for my initial checkup with the doc today and, being juuuuust below morbid obesity with a BMI of 34, asked her about semaglutide as an adjunct to exercise controlling calorie intake. She's referring me to a weight loss clinic at my local public hospital where I can be assessed for suitability (If I'm not mistaken the clinic has hepatologists and endocrinologists on staff along with allied healthcare workers such as physios and nutritionists). This is great because it costs a bomb if I have to go private. The only wrinkle is that I'm oddly enough not diabetic or pre-diabetic so whether or not I'll qualify for socialised semaglutide is unclear but we live in hope.
I was wondering if any of you had tried any of the variants of semaglutide for obesity and what your experiences have been like.
18 votes -
Novo Nordisk suggested to senior UK government officials that they could “profile” benefit claimants – those who are most likely to return to the labour market
17 votes -
Denmark is building on the success of blockbuster drugs – the country's focus on reinvestment is feeding a stream of discovery
7 votes -
First malaria vaccine slashes early childhood mortality
12 votes -
Adderall risks: Much more than you wanted to know (2017)
35 votes -
‘The tsunami just keeps coming’: Europe’s growing cocaine market
14 votes -
The Ozempic effect is coming for everything from kidney to heart disease treatments
12 votes -
Something is golden in the state of Denmark – can Novo Nordisk's success really be a problem for the Danish economy?
8 votes -
New pill helps COVID smell and taste loss fade quickly
19 votes -
Ozempic is bad for [the fast food] business
17 votes -
Woman denied medication for being of childbearing age
59 votes -
A closer look at Kowloon Walled City in Hong Kong, the most densely populated place that ever existed
40 votes -
Scottish officials approve UK’s first drug consumption room intended for safer use of illegal drugs
30 votes -
New vaccine technology could protect from future viruses and variants
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants of SARS-CoV-2 – the virus that causes...
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants of SARS-CoV-2 – the virus that causes COVID-19 – as well as other major coronaviruses, including those that caused the first SARS epidemic in 2002.
The studies in mice, rabbits and guinea pigs [...] found that the vaccine candidate provided a strong immune response against a range of coronaviruses by targeting the parts of the virus that are required for replication.
Professor Jonathan Heeney from Cambridge’s Department of Veterinary Medicine, who led the research, [said] “We wanted to come up with a vaccine that wouldn’t only protect against SARS-CoV-2, but all its relatives.”
18 votes -
Anti-COVID drug may have led to virus mutations: study
10 votes -
Nebraska woman gets two years in prison for helping teen daughter have an abortion
17 votes